REDUCTION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ADRIAMYCIN CYTO-TOXICITY FOLLOWING CELL-CYCLE ARREST BY ANGUIDINE

被引：0

作者：

TEODORI, L

BARLOGIE, B

DREWINKO, B

SWARTZENDRUBER, D

MAURO, F

机构：

[1] ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030

[2] ANDERSON HOSP & TUMOR INST,DEPT LAB MED,HOUSTON,TX 77030

[3] CNEN,DOSIMETRIA BIOFIS LAB,ROME,ITALY

来源：

CANCER RESEARCH | 1981年 / 41卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1263 / 1270

页数：8

共 50 条

[31] POTENTIATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM AND CYTO-TOXICITY BY 2,3-DIHYDRO-1H-IMIDAZOLO[1,2-B]PYRAZOLE IN THE HUMAN PROMYELOCYTIC LEUKEMIC-CELL, HL-60
GRANT, S
BHALLA, K
RAUSCHER, F
CADMAN, E
CANCER RESEARCH, 1983, 43 (11) : 5093 - 5700
[32] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
DAMON, LE
PLUNKETT, W
LINKER, CA
CANCER RESEARCH, 1991, 51 (16) : 4141 - 4145
[33] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE
KREIS, W
BUDMAN, DR
CANCER RESEARCH, 1992, 52 (13) : 3818 - 3819
[34] DIRECT RELATIONSHIP OF MARROW CELL-GROWTH AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM
KARP, JE
DONEHOWER, RC
DOLE, GB
BURKE, PJ
CANCER RESEARCH, 1984, 44 (11) : 5046 - 5050
[35] CYTO-TOXICITY AND CELL-CYCLE EFFECTS OF PROSTAGLANDINS (PGS) ON HUMAN AND MURINE MELANOMA-CELLS
BHUYAN, BK
ADAMS, EG
LI, LH
TIMMINS, L
BADIHER, GJ
BARDEN, K
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 354 - 354
[36] CELL-CYCLE CHANGES AND CYTO-TOXICITY OF SULFASALAZINE IN CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS
SHARON, P
DRAB, EA
LINDERMAN, MA
WEIDMAN, SW
SABESIN, SM
RUBIN, DB
CLINICAL RESEARCH, 1988, 36 (06): : A873 - A873
[37] CELL-CYCLE DEPENDENCE OF HOECHST-33342 DYE CYTO-TOXICITY ON SORTED LIVING CELLS
WIEZOREK, C
HISTOCHEMISTRY, 1984, 81 (05) : 493 - 495
[38] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLURACIL FOLLOWING THE REPEATED INTRAVENOUS ADMINISTRATION OF HIGH-DOSE AND INTERMEDIATE-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE - REPLY
DAMON, LE
PLUNKETT, W
LINKER, CA
CANCER RESEARCH, 1992, 52 (13) : 3819 - 3820
[39] INVIVO STUDIES ON HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE (HDARA-C) AND 1-BETA-D-ARABINOFURANOSYLURACIL (ARA-U) WITH RESPECT TO PHARMACOKINETICS, CELL-KINETICS, AND CYTO-TOXICITY IN A RAT MYELOCYTIC-LEUKEMIA MODEL (BNML)
COLLY, LP
WILLEMZE, R
HONDERS, W
VANDERHOORN, F
EDELBROEK, PM
SEMINARS IN ONCOLOGY, 1985, 12 (02) : 49 - 54
[40] ANTIVIRAL ACTIVITIES OF ACYL DERIVATIVES OF 2,2'-ANHYDRO-1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CELL-CULTURE
SATO, K
NOMURA, A
MOFFATT, JG
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) : 191 - 197

← 1 2 3 4 5 →